To prove this hypothesis, we first used ChIP assay to detect the binding of EZH2 and PDCD4 promoter region in ESCC cells without any treatment (Additional file 2: Fig. S8). The gene discussed is EZH2; the disease is esophageal squamous cell carcinoma.